Filter
307
Filtered Results: 307
Text search:
NRTIs
Featured
Recommendations
29
New Publications
93
Language
Document type
No document type
219
Guidelines
39
Studies & Reports
33
Manuals
4
Training Material
4
Strategic & Response Plan
3
Fact sheets
3
Brochures
1
Situation Updates
1
Countries / Regions
India
20
Tanzania
18
Kenya
10
South Africa
9
Nepal
8
Zambia
7
Namibia
6
Ethiopia
5
Rwanda
4
Nigeria
4
Malawi
4
Mozambique
4
Bangladesh
4
Ukraine
3
Cambodia
3
Uganda
3
Indonesia
3
Myanmar / Burma
3
Eswatini/ Swaziland
3
Thailand
2
Lesotho
2
Ghana
2
Senegal
2
Estonia
2
Zimbabwe
2
Germany
2
Western and Central Europe
2
Botswana
2
North Macedonia
1
Sierra Leone
1
Gambia
1
Cameroon
1
Syria
1
Albania
1
Burkina Faso
1
Philippines
1
Global
1
Africa
1
Latin America and the Carribbean
1
Lithuania
1
South–East Asia Region
1
United Kingdom
1
Eastern Europe
1
Russia
1
Yemen
1
Bhutan
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
130
Clinical Guidelines
36
Women & Child Health
16
Capacity Building
9
Public Health
8
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
HIV
108
TB
22
Mental Health
6
Refugee
6
Caregiver
5
COVID-19
4
Pharmacy
4
AMR
3
Planetary Health
2
NTDs
2
Conflict
2
Rapid Response
1
Social Ethics
1
Health Financing Toolbox
1
NCDs
1
Global Health Education
1
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
Accessed: 19.10.2019
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
www.i-Base.info
Accessed: 28.11.2019
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
WHO GUIDELINES REVIEW COMMITTEE
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
This report presents examples from different agencies on how they approached community engagement in their Covid-19 responses, the tools and methodologies used, as well as the challenges they encountered and how they attempted to overcome these. It discusses what community engagement means to the va...
In concordance with the global and WHO activities on ARC, the Ministry of Health and Family Welfare (MoHFW) in Bangladesh has come forward and initiative was taken to conduct program for containment of antimicrobial resistance in Bangladesh. Director, Disease Control and Line Director, Communicable ...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...
